News
China's WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum. The contract development and ...
SHANGHAI, March 31, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides ... The site presented its state-of-the-art infrastructure, the team's strong technical expertise, and the ...
In doing so, WuXi AppTec (603259.SH; 2359.HK) was able to cash out its holdings at a favorable price, just before the unexpected scale of Trump's tariffs began sending financial markets into a ...
It also acquired one other Mendota Heights WuXi AppTec location at 2520 Pilot Knob Road. WuXi AppTec is headquartered in Shanghai, China.
Hosted on MSN5mon
Shanghai to support local biopharma firms’ overseas push, regulatory product complianceShanghai’s municipal government seeks to ... Complete Genomics, MGI, Wuxi AppTec and Wuxi Biologics – and establishes an inter-agency process for identifying additional companies.
In response to the news that the US will soon announce significant import tariffs on pharmaceuticals, Edward Hu, Vice Chairman and Global Chief Investment Officer of WUXI APPTEC (02359.HK), said ...
WUXI APPTEC (02359.HK) 0.000 (0.000%) Short selling $84.02M; Ratio 30.526% , peaking at $61.15 after opening up 11.72%, last posted at $58.95, up 7.97%, with 4.0337 million shares traded ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results